Deucrictibant, an experimental treatment for hereditary angioedema (HAE), now has shown promising efficacy as an on-demand and prophylactic,…
Articles by Patricia Inácio, PhD
Orladeyo (berotralstat), an oral therapy designed to prevent swelling attacks in adults and adolescents with hereditary angioedema (HAE), has now…
Hereditary angioedema (HAE) is marked by frequent attacks and high disease burden in Canadian patients, who waited a median…
A dozen new mutations in the SERPING1 gene were identified in Slovakia as the cause of hereditary angioedema (HAE)…
The use of vaccines against SARS-CoV-2, the virus that causes COVID-19, was not linked to an increased risk of disease…
Treatment with tranexamic acid was safe and not linked to a higher risk of worse outcomes in people who developed…
Preventive treatment with Takhzyro (lanadelumab) reduced swelling attack frequency and improved quality of life in Japanese patients with…
A 2-year-old girl with Down syndrome who was diagnosed with a rare form of hereditary angioedema…
In a 39-year-old man in France, hereditary angioedema (HAE) manifested with stroke-like symptoms, including weakness on one side of…
Long-term use of attenuated androgens — male hormones used as a preventive treatment — may increase the risk for other…